The indices of the immune status of intact animals after treatment course with MIGU-1 (a conjunction of germanium and nicotine acid) and new heptral hepatoprotector were studied. It was ascertained that these medicaments didn’t influence immune status and biochemical parameters negatively if using them in medium therapeutic doses. Using these medicaments in high doses leaded to decreasing of T- and B-lymphocytes amount and activity.
